re.Mind Capital

Remind.vc, officially known as re.Mind Capital, is a venture capital firm with a distinct focus on mental and neurological health. Launched as part of Christian Angermayer’s Apeiron Investment Group, re.Mind Capital prioritizes investments in groundbreaking companies aimed at solving global mental health challenges. The firm’s investment strategy revolves around supporting companies in neuroscience, life sciences, and digital health that offer innovative solutions to address the growing prevalence of mental health issues. Founded in 2020 and headquartered in Malta, re.Mind Capital has quickly built an impressive portfolio of pioneering companies. These include Blackrock Neurotech, which focuses on brain-computer interface technology, and other cutting-edge ventures pushing the boundaries of mental health treatment and neurotechnologies. The firm is committed to backing visionary founders who are creating transformative products and services that can fundamentally improve well-being, happiness, and freedom for millions of people worldwide. re.Mind Capital typically invests in early to mid-stage companies, offering financial backing alongside strategic guidance and a broad network of industry connections. With its strong mission-driven approach and a deep commitment to advancing the field of mental health, re.Mind Capital is positioned as a leader in the rapidly growing space of mental health innovation.